Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.
about
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Open-Label, Phase II Study to ...... With Periodic Fever Syndrome.
@en
type
label
Open-Label, Phase II Study to ...... With Periodic Fever Syndrome.
@en
prefLabel
Open-Label, Phase II Study to ...... With Periodic Fever Syndrome.
@en
P2093
P2860
P356
P1476
Open-Label, Phase II Study to ...... With Periodic Fever Syndrome.
@en
P2093
Angel Robles
Berta López-Montesinos
Estibaliz Iglesias
Guido Junge
Inmaculada Calvo
Jordi Yagüe
Romain Banchereau
Seunghee Hong
Virginia Pascual
Yolandi Joubert
P2860
P304
P356
10.1002/ART.40146
P577
2017-05-08T00:00:00Z